Results 21 to 30 of about 51,365 (299)

Modern Approaches to Optimization of the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency

open access: yesGastroenterologìa, 2014
The article describes the etiology and current diagnostic methods of investigation of exocrine pancreatic insufficiency, in particular non-invasive 13C-mixed triglyceride test, allowing not only to determine indirectly the activity of pancreatic lipase ...
S.M. Tkach, O.V. Shvets
doaj   +1 more source

Pancreatic enzyme replacement therapy for people with cystic fibrosis. [PDF]

open access: yesCochrane Database Syst Rev, 2016
Most people with cystic fibrosis (80% to 90%) need pancreatic enzyme replacement therapy to prevent malnutrition. Enzyme preparations need to be taken whenever food is taken, and the dose needs to be adjusted according to the food consumed. A systematic review on the efficacy and safety of pancreatic enzyme replacement therapy is needed to guide ...
Somaraju UR, Solis-Moya A.
europepmc   +7 more sources

Infected Necrosis in Severe Pancreatitis - Combined Nonsurgical Multi-Drainage with Directed Transabdominal High-Volume Lavage in Critically Ill Patients [PDF]

open access: yes, 2009
Background: Infection of pancreatic necrosis is a life-threatening complication during the course of acute pancreatitis. In critically ill patients, surgical or extended endoscopic interventions are associated with high morbidity and mortality. Minimally
A. Meining   +31 more
core   +1 more source

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model. [PDF]

open access: yes, 2012
Pancreatic duct glands (PDGs) have been hypothesized to give rise to pancreatic intraepithelial neoplasia (PanIN). Treatment with the glucagon-like peptide (GLP)-1 analog, exendin-4, for 12 weeks induced the expansion of PDGs with mucinous metaplasia and
Butler, Peter C   +5 more
core   +1 more source

Thyroxine-binding globulin: investigation of microheterogeneity [PDF]

open access: yes, 1981
Preparations of T4-binding globulin (TBG) from human serum was performed using only two affinity chromatography steps. Purity of the protein was demonstrated by a single band in overloaded disc and sodium dodecyl sulfate electrophoresis, equimolar ...
Gärtner, Roland   +4 more
core   +1 more source

Pancreatic enzyme replacement therapy after gastric resection: An update [PDF]

open access: yesDigestive and Liver Disease, 2018
Exocrine pancreatic insufficiency (EPI) is one of the possible mechanisms of fat maldigestion following gastric surgery, together with reduced food intake, loss of gastric reservoir, small bowel bacterial overgrowth and rapid small bowel transit. Oral pancreatic enzyme replacement therapy (PERT) is the mainstay of treatment for EPI.
Filippo, Antonini   +4 more
openaire   +2 more sources

Place of enzyme replacement therapy in the treatment of chronic pancreatitis in children

open access: yesМедицинский совет, 2014
Enzyme preparations are commonly used in pediatric practice. Enzymes play a relevant role in replacement and symptomatic therapy of chronic pancreatitis accompanied by exocrine pancreatic insufficiency.
A. V. Tumarenko, V. V. Skvortsov
doaj   +1 more source

Clinical and pharmacological approaches to the management of exocrine pancreatic insufficiency in chronic pancreatitis

open access: yesМедицинский совет, 2021
Chronic pancreatitis is a multifactorial disease in which repeated episodes of inflammation of the pancreas contribute to the development of fibrous tissue, leading to chronic pain, as well as exocrine and endocrine insufficiency.
V. N. Drozdov   +7 more
doaj   +1 more source

Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer [PDF]

open access: yesCochrane Database Syst Rev, 2018
Nofal Y   +6 more
europepmc   +3 more sources

Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor. [PDF]

open access: yes, 2012
Pancreatic neuroendocrine tumors (PNETs) are relatively rare tumors that arise in the endocrine cells of the pancreas. Historically, somatostatin analogues have been used in this disease primarily for symptom control and, to a limited extent, disease ...
Devata, Sumana, Kim, Edward J
core   +2 more sources

Home - About - Disclaimer - Privacy